MedPath

Felbamate

{'content': {'@styleCode': 'bold'}}

Approved
Approval ID

c0c15d60-1171-11e1-9be0-0002a5d5c51b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 21, 2018

Manufacturers
FDA

Wallace Pharmaceuticals Inc.

DUNS: 962531955

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

felbamate

PRODUCT DETAILS

NDC Product Code51525-0442
Application NumberNDA020189
Marketing CategoryC73605
Route of AdministrationORAL
Effective DateFebruary 21, 2018
Generic Namefelbamate

INGREDIENTS (1)

FELBAMATEActive
Quantity: 600 mg in 5 mL
Code: X72RBB02N8
Classification: ACTIB

felbamate

PRODUCT DETAILS

NDC Product Code51525-0430
Application NumberNDA020189
Marketing CategoryC73605
Route of AdministrationORAL
Effective DateFebruary 21, 2018
Generic Namefelbamate

INGREDIENTS (1)

FELBAMATEActive
Quantity: 400 mg in 1 1
Code: X72RBB02N8
Classification: ACTIB

felbamate

PRODUCT DETAILS

NDC Product Code51525-0431
Application NumberNDA020189
Marketing CategoryC73605
Route of AdministrationORAL
Effective DateFebruary 21, 2018
Generic Namefelbamate

INGREDIENTS (1)

FELBAMATEActive
Quantity: 600 mg in 1 1
Code: X72RBB02N8
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Felbamate - FDA Drug Approval Details